Corcept to present new data on relacorilant in ovarian cancer at ESMO
PositiveFinancial Markets

Corcept Therapeutics is set to present new data on relacorilant, a promising treatment for ovarian cancer, at the upcoming ESMO conference. This presentation is significant as it could provide insights into the effectiveness of relacorilant, potentially offering hope to patients battling this challenging disease. The findings may influence future treatment protocols and enhance understanding of ovarian cancer therapies.
— Curated by the World Pulse Now AI Editorial System